Who owns ACELRX PHARMACEUTICALS INC?
- Ticker: ACRX
- CUSIP Number: 00444t209
Tip: Access positions for across all investors
Analyze quarterly positions in Acelrx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Acelrx Pharmaceuticals stock
Who bought or sold ACELRX PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Nantahala Capital Management | 2.0M | $1.5M | 3% | Dec 2023 |
|
Rosalind Advisors | 759k | $558k | 100% | Dec 2023 |
|
Cantor Fitzgerald, L. P. | 712k | $300M | 0% | Dec 2023 |
|
Rock Springs Capital Management | 317k | $184k | 0% | Sep 2023 |
|
Tang Capital Management | 195k | $143k | 0% | Dec 2023 |
|
Vanguard Group | 177k | $130k | 3% | Dec 2023 |
|
Values First Advisors | 135k | $99k | 10% | Dec 2023 |
|
Geode Capital Management | 124k | $72k | 80% | Sep 2023 |
|
Susquehanna International | 121k | $70k | 247% | Sep 2023 |
|
BlackRock | 92k | $51k | 0% | Sep 2023 |
|
Virtu Financial | 66k | $48k | 156% | Dec 2023 |
|
Citadel Advisors | 30k | $22k | 100% | Dec 2023 |
|
Turtle Creek Wealth Advisors | 24k | $17k | 100% | Dec 2023 |
|
State Street Corporation | 22k | $13k | 0% | Sep 2023 |
|
Millennium Management | 21k | $16k | -51% | Dec 2023 |
|
Morgan Stanley | 15k | $8.5k | 581% | Sep 2023 |
|
Jane Street | 12k | $9.0k | -21% | Dec 2023 |
|
UBS Group | 11k | $8.3k | 15764% | Dec 2023 |
|
Northern Trust | 11k | $6.3k | 0% | Sep 2023 |
|
Tower Research Capital | 7.8k | $4.5k | 10% | Sep 2023 |
|
Advisor Group Holdings | 1.4k | $930.187500 | -17% | Dec 2023 |
|
Wells Fargo & Company | 901.00 | $662.685500 | 1% | Dec 2023 |
|
Goss Wealth Management | 500.00 | $290.000000 | 0% | Sep 2023 |
|
Advisory Services Network | 150.00 | $109.995000 | 100% | Dec 2023 |
|
Silicon Valley Capital Partners | 137.00 | $100.996400 | 0% | Dec 2023 |
|
Newbridge Financial Services Group | 125.00 | $73.000000 | 0% | Sep 2023 |
|
Jpmorgan Chase & Co | 54.00 | $39.997800 | 38% | Dec 2023 |
|
Absolute Investment Management | 50.00 | $37.000000 | 0% | Dec 2023 |
|
FMR | 26.00 | $14.999400 | -49% | Sep 2023 |
|
Global Retirement Partners | 23.00 | $17.999800 | 0% | Dec 2023 |
|
Bank of America Corporation | 22.00 | $16.000600 | 100% | Dec 2023 |
|
Royal Bank of Canada | 19.00 | $0 | 0% | Dec 2023 |
|
Qube Research & Technologies | 1.00 | $1.000000 | 100% | Sep 2023 |
|
Who sold out of Acelrx Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Cowen And Company | Sep 2023 | 116k | $67k |
Bridgeway Capital Management | Jun 2023 | 12k | $14k |
Cubist Systematic Strategies | Sep 2023 | 10k | $5.9k |
Foundations Investment Advisors | Sep 2023 | 10k | $5.8k |